Last 12 months
Inside the activity.
1 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009963 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,158 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
keller brettDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009964 · doc4.xml · derivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
keller brettDirector
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009964 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,940 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
MURRAY EILEEN KDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,467 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009966 · doc4.xml · derivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,467 Underlying: Common Stock · 2,467 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009966 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,950 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Zavery AmitDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009968 · doc4.xml · derivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009968 · doc4.xml · nonDerivative · entry 1 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,255 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Nazareth Annette L.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009967 · doc4.xml · derivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Nazareth Annette L.Director
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009967 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,943 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Markus Maura A.Director
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009965 · doc4.xml · derivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Markus Maura A.Director
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009965 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,246.102 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Carter Pamela LDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,844 | $0.00 Strike: $227.56 | $0.00 |
DisclosureSEC source: 0001225208-24-009961 · doc4.xml · derivative · entry 2 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,844 shares Expires 2034-11-14 F2 · derivative.exercise_date: Stock options vest immediately upon grant. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 19:32 UTC |
Carter Pamela LDirector
|
GrantCommon Stock | 458 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009961 · doc4.xml · nonDerivative · entry 1 Carter Pamela L · CIK 0001396958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,126 F1 · price: The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,888 | $0.00 Strike: $98.31 | $0.00 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · derivative · entry 6 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,888 shares Expires 2029-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,920 | $0.00 Strike: $117.34 | $0.00 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · derivative · entry 5 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,920 shares Expires 2030-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
SaleCommon Stock | 3,459 | $227.65 | $787,456.22 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 4 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,115.696 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.190 - $227.955, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
SaleCommon Stock | 3,351 | $227.65 | $762,869.56 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 3 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,574.696 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.190 - $227.955, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionCommon Stock | 3,888 | $98.31 | $382,229.28 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 2 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,925.696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2024 Filed Nov 12, 2024 15:47 UTC |
Matlin LauraCVP, Deputy GC and CCO
|
Exercise / conversionCommon Stock | 3,920 | $117.34 | $459,972.80 |
DisclosureSEC source: 0001225208-24-009864 · doc4.xml · nonDerivative · entry 1 Matlin Laura · CIK 0001658944 · CVP, Deputy GC and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,037.696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,180 | $0.00 Strike: $173.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 6 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,180 Underlying: Common Stock · 1,180 shares Expires 2031-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,120 | $0.00 Strike: $176.18 | $0.00 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 5 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,121 Underlying: Common Stock · 1,120 shares Expires 2033-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,365 | $0.00 Strike: $133.74 | $0.00 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · derivative · entry 4 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,365 Underlying: Common Stock · 1,365 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionCommon Stock | 1,120 | $176.18 | $197,321.60 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 3 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionCommon Stock | 1,180 | $173.00 | $204,140.00 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 2 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Nazareth Annette L.Director
|
Exercise / conversionCommon Stock | 1,365 | $133.74 | $182,555.10 |
DisclosureSEC source: 0001225208-24-009847 · doc4.xml · nonDerivative · entry 1 Nazareth Annette L. · CIK 0001846828 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Markus Maura A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,469 | $0.00 Strike: $45.09 | $0.00 |
DisclosureSEC source: 0001225208-24-009846 · doc4.xml · derivative · entry 3 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,469 shares Expires 2024-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Markus Maura A.Director
|
SaleCommon Stock | 3,880 | $227.02 | $880,835.66 |
DisclosureSEC source: 0001225208-24-009846 · doc4.xml · nonDerivative · entry 2 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,788.102 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.86 - $227.155, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Markus Maura A.Director
|
Exercise / conversionCommon Stock | 6,469 | $45.09 | $291,687.21 |
DisclosureSEC source: 0001225208-24-009846 · doc4.xml · nonDerivative · entry 1 Markus Maura A. · CIK 0001571545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,668.102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,969 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · derivative · entry 7 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,163 Underlying: Common Stock · 5,969 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $93.88 | $0.00 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · derivative · entry 6 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,132 Underlying: Common Stock · 3,000 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 5,045 | $226.82 | $1,144,286.72 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 5 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,689 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 3,177 | $226.82 | $720,594.43 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 4 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,734 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
SaleCommon Stock | 2,535 | $226.82 | $574,978.56 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 3 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,911 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.52 - $227.30, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 3,000 | $93.88 | $281,640.00 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 2 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 17:49 UTC |
Carey Thomas PCorporate VP
|
Exercise / conversionCommon Stock | 5,969 | $93.88 | $560,369.72 |
DisclosureSEC source: 0001225208-24-009845 · doc4.xml · nonDerivative · entry 1 Carey Thomas P · CIK 0001731499 · Corporate VP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,999 | $0.00 Strike: $67.32 | $0.00 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · derivative · entry 7 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,999 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,764 | $0.00 Strike: $51.95 | $0.00 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · derivative · entry 6 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,764 shares Expires 2026-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 9,571 | $220.21 | $2,107,645.22 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 5 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,136.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 7,481 | $220.21 | $1,647,402.98 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 4 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,707.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
SaleCommon Stock | 7,133 | $220.21 | $1,570,769.34 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 3 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,188.8948 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.54 - $221.24, inclusive. The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionCommon Stock | 8,764 | $51.95 | $455,289.80 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 2 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,321.8948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2024 Filed Nov 8, 2024 17:30 UTC |
DESCHUTTER DOUGLAS RICHARDCo-President ICS
|
Exercise / conversionCommon Stock | 8,999 | $67.32 | $605,812.68 |
DisclosureSEC source: 0001225208-24-009795 · doc4.xml · nonDerivative · entry 1 DESCHUTTER DOUGLAS RICHARD · CIK 0001391093 · Co-President ICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,557.8948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
Duelks Robert NDirector
|
GrantCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009199 · doc4.xml · nonDerivative · entry 1 Duelks Robert N · CIK 0001477044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,749 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
FLOWERS MELVIN LDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009202 · doc4.xml · nonDerivative · entry 1 FLOWERS MELVIN L · CIK 0001196490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,700 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
keller brettDirector
|
GrantCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009201 · doc4.xml · nonDerivative · entry 2 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,482 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
keller brettDirector
|
GrantCommon Stock | 32 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009201 · doc4.xml · nonDerivative · entry 1 KELLER BRETT · CIK 0001214608 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,468 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 12:27 UTC |
BRUN LESLIE ADirector
|
GrantCommon Stock | 115 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009198 · doc4.xml · nonDerivative · entry 1 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,433 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009203 · doc4.xml · nonDerivative · entry 2 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,333 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
MURRAY EILEEN KDirector
|
GrantCommon Stock | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009203 · doc4.xml · nonDerivative · entry 1 MURRAY EILEEN K · CIK 0001341752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,337 F1 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued in lieu of cash compensation under the Director Deferred Compensation Program (the "DCUs"). This amount represents a like number of shares of Broadridge common stock. The DCUs vest in full upon grant and will settle in shares of Broadridge common stock commencing with the director's separation from service with Broadridge. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 16:27 UTC |
Zavery AmitDirector
|
GrantCommon Stock | 12 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009206 · doc4.xml · nonDerivative · entry 2 Zavery Amit · CIK 0001781064 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,797 F2 · shares: The reported transaction reflects the award of additional Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan in connection with the payment of Broadridge's regular quarterly dividend on the common stock underlying the Deferred Stock Units previously issued. This amount represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.